Respironics Inc. announced the FDA clearance of the I-neb Adaptive Aerosol Delivery (AAD) System for the aerosolization of liquid medication approved for use with the I-neb AAD System.
The device is cleared for use by the patient in the home care, nursing home, sub-acute institution or hospital environment.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now